AAPS – The Use of Blood Microsampling for the Quantitative Bioanalysis of Pharmaceuticals in Early Development

//AAPS – The Use of Blood Microsampling for the Quantitative Bioanalysis of Pharmaceuticals in Early Development

AAPS – The Use of Blood Microsampling for the Quantitative Bioanalysis of Pharmaceuticals in Early Development

By | 2015-01-15T13:47:16+00:00 December 15th, 2014|Video|Comments Off on AAPS – The Use of Blood Microsampling for the Quantitative Bioanalysis of Pharmaceuticals in Early Development

About the Author:

MPI Research, with global headquarters in Mattawan, Mich., provides safety evaluation, discovery, bioanalytical and analytical services to the biopharmaceutical, medical device, animal health, and chemical industries. The company offers comprehensive imaging solutions including preclinical imaging, radiochemistry, and data analysis. Scientific knowledge and experience, responsiveness, integrity, trust, teamwork, and dedication to strong and enduring Sponsor relationships are the defining attributes that characterize MPI Research as a high-performance, high-quality organization that is committed to bringing safer and more effective products to the world.